The Safety Rates Drug Report

Member Login
2004.Q1    2004.Q2    2004.Q3    2004.Q4    2005.Q1    2005.Q2    2005.Q3    2005.Q4    2006.Q1    2006.Q2    2006.Q3    2006.Q4    2007.Q1    2007.Q2    2007.Q3    2007.Q4    2008.Q1    2008.Q2    2008.Q3    2008.Q4    2009.Q1    2009.Q2    2009.Q3    2009.Q4    2010.Q1    2010.Q2    2010.Q3    2010.Q4    2011.Q1    2011.Q2    2011.Q3    2011.Q4    2012.Q1    2012.Q2    2012.Q3    2012.Q4    2013.Q1    2013.Q2    2013.Q3    2013.Q4    2014.Q1    2014.Q2    2014.Q3    2014.Q4    2015.Q1    2015.Q2    2015.Q3    2015.Q4    2016.Q1    2016.Q2    2016.Q3   

Drug     Injury     Quarter    

Person who experienced the adverse event (patient)

Event ID CASEID CASEVERSION I F COD EVENT DT MFR DT INIT FDA DT FDA DT REPT COD AUTH NUM MFR NUM MFR SNDR LIT REF AGE AGE COD AGE GRP GNDR COD E SUB WT WT COD REPT DT TO MFR OCCP COD REPORTER COUNTRY OCCR COUNTRY
115121224 11512122 4 F 20160501 20160811 20150916 20160823 PER US-ASTRAZENECA-2013SE69272 ASTRAZENECA 27556.00 DY M Y 80.70000 KG 20160823 US US

Drug(s) used by person

Event ID CASEID DRUG SEQ ROLE COD DRUGNAME PROD AI VAL VBM ROUTE DOSE VBM CUM DOSE CHR CUM DOSE UNIT DECHAL RECHAL LOT NUM EXP DT NDA NUM DOSE AMT DOSE UNIT DOSE FORM DOSE FREQ
115121224 11512122 1 PS SYMBICORT BUDESONIDEFORMOTEROL FUMARATE DIHYDRATE 1 Respiratory (inhalation) 160/4.5 MCG TWO PUFFS TWO TIMES A DAY 21929
115121224 11512122 2 SS SYMBICORT BUDESONIDEFORMOTEROL FUMARATE DIHYDRATE 1 Respiratory (inhalation) 80/4.5,UNKNOWN 21929
115121224 11512122 3 SS SYMBICORT BUDESONIDEFORMOTEROL FUMARATE DIHYDRATE 1 Respiratory (inhalation) 160/4.5 MCG,UNKNOWN 21929
115121224 11512122 4 SS TUDORZA PRESSAIR ACLIDINIUM BROMIDE 1 Respiratory (inhalation) ONE INHALATION TWICE PER DAY 0 INHALATION POWDER
115121224 11512122 5 SS LISINOPRIL/HCTZ HYDROCHLOROTHIAZIDELISINOPRIL 1 Oral 0 1 DF TABLET QD
115121224 11512122 6 SS DALIRESP ROFLUMILAST 1 Oral Y 0 1 DF TABLET QOD
115121224 11512122 7 SS DALIRESP ROFLUMILAST 1 Oral Y 0 .5 DF TABLET QD
115121224 11512122 8 SS DALIRESP ROFLUMILAST 1 Oral ONE HALF OF A PILL EVERY OTHER DAY FOR 2 WEEKS Y 0 TABLET
115121224 11512122 9 SS DALIRESP ROFLUMILAST 1 Oral Y 0 1 DF TABLET QD
115121224 11512122 10 C ATORVASTATIN ATORVASTATIN 1 0 40 MG QD
115121224 11512122 11 C NOVOLOG INSULIN ASPART 1 THREE TIMES A DAY 0
115121224 11512122 12 C LEVEMIR INSULIN DETEMIR 1 ONCE DAILY 0
115121224 11512122 13 C CARDIO 2 0 240 MG QD
115121224 11512122 14 C SPIRIVA TIOTROPIUM BROMIDE MONOHYDRATE 1 0
115121224 11512122 15 C LANTIS INSULIN 2 Subcutaneous 48 0

Indications of drugs used

Event ID CASEID INDI DRUG SEQ INDI PT
115121224 11512122 1 Chronic obstructive pulmonary disease
115121224 11512122 2 Chronic obstructive pulmonary disease
115121224 11512122 3 Chronic obstructive pulmonary disease
115121224 11512122 4 Chronic obstructive pulmonary disease
115121224 11512122 6 Chronic obstructive pulmonary disease
115121224 11512122 7 Chronic obstructive pulmonary disease
115121224 11512122 8 Chronic obstructive pulmonary disease
115121224 11512122 9 Chronic obstructive pulmonary disease
115121224 11512122 10 Blood cholesterol abnormal
115121224 11512122 11 Diabetes mellitus
115121224 11512122 12 Diabetes mellitus
115121224 11512122 15 Type 2 diabetes mellitus

Outcome of event

no results found

Reactions reported

Event ID CASEID DRUG REC ACT PT
115121224 11512122 Abdominal discomfort
115121224 11512122 Circumstance or information capable of leading to medication error
115121224 11512122 Contusion
115121224 11512122 Dysgeusia
115121224 11512122 Dyspnoea
115121224 11512122 Nausea
115121224 11512122 Off label use

Reporting Sources (this data is often not reported and may therefore be missing here)

no results found

Therapies reported

Event ID CASEID DSG DRUG SEQ START DT END DT DUR DUR COD
115121224 11512122 6 20160404 20160518 0
115121224 11512122 9 201605 0